Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Conssegna Pharma
Pittsburgh, Pennsylvania, United States
- Ownership
- Private
- Employees
- ~30
- Development stage
- Other
01
Overview
Consegna Pharma is a specialty pharmaceutical company based in Pittsburgh that focuses on developing long-acting injectable (LAI) medications by reformulating established, FDA-approved drugs. The company utilizes its proprietary AI-driven Computational Drug Delivery™ platform to design sustained-release formulations more efficiently than traditional methods. Its lead program, CP216, is a long-acting naloxone formulation designed to provide 12-24 hours of protection against renarcotization following an opioid overdose. In 2022, Consegna expanded its portfolio by acquiring Fathom Pharma, adding long-acting treatments for chronic pain to its pipeline.
- Therapeutic areas
- PsychiatryNeurology
- Modalities
- Small moleculeLong-acting injectablePolymer-based drug delivery therapy
- Industry
- Biotech
02
Partnerships
National Institute on Drug AbuseUniversity of Pittsburgh
Beyond the preview
Go deeper on Conssegna Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Conssegna Pharma.